BREKIYA Trademark

Trademark Overview

On Tuesday, June 15, 2021, a trademark application was filed for BREKIYA with the United States Patent and Trademark Office. The USPTO has given the BREKIYA trademark a serial number of 90775004. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Tuesday, June 4, 2024. This trademark is owned by Amneal Pharmaceuticals LLC. The BREKIYA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of migraine
brekiya

General Information

Serial Number90775004
Word MarkBREKIYA
Filing DateTuesday, June 15, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of migraine

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, September 2, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmneal Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameAmneal Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807

Trademark Events

Event DateEvent Description
Friday, June 18, 2021NEW APPLICATION ENTERED
Thursday, September 2, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 26, 2022ASSIGNED TO EXAMINER
Monday, February 28, 2022NON-FINAL ACTION WRITTEN
Monday, February 28, 2022NON-FINAL ACTION E-MAILED
Monday, February 28, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, March 16, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, March 16, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 18, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 21, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 13, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, December 13, 2022SOU EXTENSION 1 FILED
Tuesday, December 13, 2022SOU EXTENSION 1 GRANTED
Thursday, December 15, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 2, 2023SOU EXTENSION 2 FILED
Friday, June 2, 2023SOU EXTENSION 2 GRANTED
Tuesday, June 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 3 FILED
Tuesday, December 5, 2023SOU EXTENSION 3 GRANTED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 4 FILED
Tuesday, June 4, 2024SOU EXTENSION 4 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

brekiya migraine treatment preparations pharmaceutical